PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 1554958

Gallium nitrate.

T E Hughes·L A Hansen
View original source ↗Export metadata ↓

Abstract

OBJECTIVE: To evaluate the therapeutic role of gallium nitrate in the treatment of hypercalcemia associated with malignancy and related disease states. DATA SOURCES: A literature search of English-language studies involving gallium nitrate for the period 1966-1991 using MEDLINE and the bibliographies of relevant articles. STUDY SELECTION: Because of the limited number of studies, all clinical trials were reviewed, with particular emphasis on Phase III comparative trials. Related investigative studies on the pharmacology, pharmacokinetics, and toxicity of gallium nitrate were also reviewed. DATA EXTRACTION: Two appraisers independently abstracted data from available clinical trials and evaluated trial quality. RESULTS OF DATA SYNTHESIS: Two Phase III comparative trials evaluating gallium nitrate in the treatment of hypercalcemia of malignancy have been completed. Gallium nitrate was shown to be superior to both calcitonin and etidronate disodium, based on the comparative percentage of patients achieving normocalcemia and the subsequent duration of normocalcemia. Both trials employed similar methodology. Positive therapeutic effects of gallium nitrate have also been demonstrated in small, noncomparative trials for hypercalcemia associated with parathyroid carcinoma, Paget's disease of bone, and osteolytic bone metastases. CONCLUSIONS: Gallium nitrate is effective in the treatment of hypercalcemia associated with malignancy and is appropriate for formulary addition. In certain clinical situations, it may be clearly advantageous over such agents as calcitonin, plicamycin, and etidronate. Further investigation is needed to define the limitations of nephrotoxicity and the therapeutic potential for other indications. Further comparative clinical trials of gallium nitrate versus bisphosphonates and plicamycin could also help define its relative clinical benefit.

Explore related subjects

GalliumHumansHypercalcemiaNeoplasmsClinical TrialJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

T E Hughes, L A Hansen. 1992. Gallium nitrate.. https://doi.org/10.1177/106002809202600310

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2002

The three-dimensional structure of the gallium complex of azoverdin, a siderophore of Azomonas macrocytogenes ATCC 12334, determined by NMR using residual dipolar coupling constants.

In iron-deficient conditions, Azomonas macrocytogenes ATCC 12334 excretes a fluorescent siderophore called azoverdin, which is composed of a six-amino-acid peptide chain linked to a chromophore. Azoverdin chelates iron(III) very strongly, solubilizing it and transporting it back into the cells using an outer-membrane receptor. This compound is related to the pyoverdins, the peptidic siderophores of Pseudomonas, but differs in the site on the chromophore at which the peptide is covalently linked. This feature identifies azoverdin as a member of a new class of pyoverdins: the isopyoverdins. We report the three-dimensional structure of azoverdin-Ga(III) in solution. The use of orientational constraints obtained from the measurement of residual dipolar couplings using samples dissolved in a liquid crystalline medium allowed us to define the absolute configuration of the metal complex, which is Delta. The structure is characterized by a U-shape adopted by the peptide chain, with the N(delta)-acetyl-N(delta)-hydroxyornithine side chains adopting extended conformations in order to chelate the gallium ion. This conformation leaves a large open space permitting access to the gallium ion. The structural consequences of the particular isopyoverdin chemical structure are discussed in the context of the three-dimensional structures of other pyoverdins.

Gallium↗
PubMed2002

Mass spectrometric investigation of gallium and zirconium complexes with octaethylporphyrin and tetraphenylporphyrin.

Gallium and zirconium octaethylporphyrin (OEP) and tetraphenylporphyrin (TPP) were examined by electrospray ionization (ESI) mass spectrometry. All systems were prepared in dichloromethane with addition of a stabilizing lipophilic anionic agent, sodium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (NaTFPB). In the solutions examined both monomeric and dimeric metalloporphyrins were observed. In the gallium-OEP mass spectrum the ion registered at m/z 601 was attributed to monomeric [Ga(OEP)](+) and that at m/z 1219 to the dimeric form, [[Ga(OEP)](2)OH](+). Peaks appearing in the ESI mass spectra of zirconium systems were substantially less intense, probably owing to the relatively low stability of complexes of this metal caused by its different geometry preferences. The most abundant monomeric zirconium-OEP complexes were [[Zr(OEP)OH]](+) (m/z 639) and [Zr(OEP)Cl](+) (m/z 657), and dimeric [[Zr(OEP)OH](2)](2+) (m/z 639). Analogous species were observed in the Zr(TPP) system: monomeric [[Zr(OEP)OH]](+) (m/z 719) and [Zr(TPP)Cl](+) (m/z 737) and dimeric [[Zr(TPP)OH](2)](2+) (m/z 719). In both cases series of other dimers, e.g. [[Zr(OEP)](2)O(2)H](+) (m/z 1277), [[Zr(OEP)OH](2)Cl](+) (m/z 1313), [Zr(TPP)(2)O(2)H](+), (m/z 1437), [[Zr(TPP)OH](2)OH](+) (m/z 1455) and [[Zr(TPP)OH](2)Cl](+) (m/z 1473), appeared. The results obtained confirmed the hypothesis concerning the formation of dimeric metalloporphyrins in solutions containing stabilizing lipophilic anions. It also allowed us to explain the super-Nernstian slopes of the calibration curves towards primary anions of ion-selective electrodes with membranes containing the examined metalloporphyrins.

Gallium↗
PubMed1995

71Ga and 69Ga nuclear magnetic resonance study of beta-Ga2O3: resolution of four- and six-fold coordinated Ga sites in static conditions.

71Ga and 69Ga nuclear magnetic resonance (NMR) spectra have been obtained for beta-Ga2O3 at magnetic fields of 11.7 and 7.0 T with a combination of static and spinning samples and using echo techniques. Isotropic chemical shifts and well constrained electric field gradient (EFG) tensors were measured for the GaIV and GaVI sites in beta-Ga2O3 and are reported for the first time. Due to its high quadrupolar coupling constant the GaIV site in beta-Ga2O3 is only resolved in static conditions. Analysis of spectral discontinuities obtained for different isotopes and magnetic field strengths and a method of readily obtaining very broad spectra without point by point acquisition demonstrate an approach that should be very useful in constraining the chemical shifts and quadrupole parameters involved in solid-state gallium NMR spectra.

Gallium↗